(NASDAQ: CVAC) Curevac Nv's forecast annual revenue growth rate of 34.33% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Curevac Nv's revenue in 2024 is $45,617,021.On average, 1 Wall Street analysts forecast CVAC's revenue for 2024 to be $23,326,378,522, with the lowest CVAC revenue forecast at $23,326,378,522, and the highest CVAC revenue forecast at $23,326,378,522. On average, 1 Wall Street analysts forecast CVAC's revenue for 2025 to be $9,727,720,000, with the lowest CVAC revenue forecast at $9,727,720,000, and the highest CVAC revenue forecast at $9,727,720,000.
In 2026, CVAC is forecast to generate $30,481,681,887 in revenue, with the lowest revenue forecast at $30,481,681,887 and the highest revenue forecast at $30,481,681,887.